Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial results have left investors feeling unsatisfied.

Rooted in the legacy of Sri Vasavi Thangamaaligai, a jewellery house serving customers since 1942 in Dindigul, Tamil Nadu, ...

Chandigarh: PGI's medical innovation, conceived and developed entirely in India, is set to redefine neuropathic pain ...

Explore the ONEXSUGAR, a cutting-edge handheld gaming device with dual screens, Android versatility, and powerful Snapdragon ...

The slew of litigation filed by states’ attorneys in the USA challenging Trump’s executive orders on citizenship, federal ...

Much like Swizz Beatz himself, an artist known for blending diverse genres, the DB Kind of Two GMT reflects a unique ...

But that’s exactly why we need the weird ones. The games that throw convention out the window. The games introduce mechanics ...